Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 22118960)

1.

The immunomodulatory capacity of mesenchymal stem cells.

Gebler A, Zabel O, Seliger B.

Trends Mol Med. 2012 Feb;18(2):128-34. doi: 10.1016/j.molmed.2011.10.004. Epub 2011 Nov 25. Review.

PMID:
22118960
2.

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.

Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.

Transplantation. 2007 Jul 27;84(2):231-7.

PMID:
17667815
3.

Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.

Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S.

Cell Transplant. 2011;20(5):655-67. doi: 10.3727/096368910X536473. Epub 2010 Nov 5.

PMID:
21054940
4.

Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells.

Kang JW, Kang KS, Koo HC, Park JR, Choi EW, Park YH.

Stem Cells Dev. 2008 Aug;17(4):681-93. doi: 10.1089/scd.2007.0153.

PMID:
18717642
5.

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.

Stem Cells. 2008 Jan;26(1):212-22. Epub 2007 Oct 11.

6.

Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.

Zhao S, Wehner R, Bornhäuser M, Wassmuth R, Bachmann M, Schmitz M.

Stem Cells Dev. 2010 May;19(5):607-14. doi: 10.1089/scd.2009.0345. Review.

PMID:
19824807
7.

Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.

Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH.

Transplantation. 2006 Jun 15;81(11):1589-95.

PMID:
16770249
8.

Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.

Soleymaninejadian E, Pramanik K, Samadian E.

Am J Reprod Immunol. 2012 Jan;67(1):1-8. doi: 10.1111/j.1600-0897.2011.01069.x. Epub 2011 Sep 23. Review.

PMID:
21951555
9.

Treatment of inflammatory diseases with mesenchymal stem cells.

Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A.

Inflamm Allergy Drug Targets. 2009 Jun;8(2):110-23. Review.

PMID:
19530993
10.

Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.

Poncelet AJ, Vercruysse J, Saliez A, Gianello P.

Transplantation. 2007 Mar 27;83(6):783-90.

PMID:
17414713
11.

Isolation and characterization of CD276+/HLA-E+ human subendocardial mesenchymal stem cells from chronic heart failure patients: analysis of differentiative potential and immunomodulatory markers expression.

Anzalone R, Corrao S, Lo Iacono M, Loria T, Corsello T, Cappello F, Di Stefano A, Giannuzzi P, Zummo G, Farina F, La Rocca G.

Stem Cells Dev. 2013 Jan 1;22(1):1-17. doi: 10.1089/scd.2012.0402. Epub 2012 Nov 16.

PMID:
23013234
12.

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.

Rasmusson I, Uhlin M, Le Blanc K, Levitsky V.

J Leukoc Biol. 2007 Oct;82(4):887-93. Epub 2007 Jul 3.

13.

Immunomodulatory properties of mesenchymal stromal cells.

Nauta AJ, Fibbe WE.

Blood. 2007 Nov 15;110(10):3499-506. Epub 2007 Jul 30. Review.

14.

Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.

Comoli P, Ginevri F, Maccario R, Avanzini MA, Marconi M, Groff A, Cometa A, Cioni M, Porretti L, Barberi W, Frassoni F, Locatelli F.

Nephrol Dial Transplant. 2008 Apr;23(4):1196-202. Epub 2007 Nov 19.

15.

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR.

J Biomed Sci. 2005;12(1):47-57.

PMID:
15864738
16.

[Mesenchymal stem cells and their immunological properties].

Lisianyĭ MI.

Fiziol Zh. 2013;59(3):126-34. Review. Ukrainian.

PMID:
23957174
17.

HLA-G expression is up-regulated by progesterone in mesenchymal stem cells.

Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E, Dimitrov R, Timeva T, Yunakova M, Bukarev D, Shterev A, Tivchev P, Kyurkchiev S.

Am J Reprod Immunol. 2009 Jul;62(1):25-33. doi: 10.1111/j.1600-0897.2009.00707.x.

PMID:
19527229
18.

Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.

Nasef A, Mazurier C, Bouchet S, François S, Chapel A, Thierry D, Gorin NC, Fouillard L.

Cell Immunol. 2008 May-Jun;253(1-2):16-22. doi: 10.1016/j.cellimm.2008.06.002. Epub 2008 Jul 18.

PMID:
18639869
19.

HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells.

Selmani Z, Naji A, Gaiffe E, Obert L, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.

Transplantation. 2009 May 15;87(9 Suppl):S62-6. doi: 10.1097/TP.0b013e3181a2a4b3.

PMID:
19424010
20.

The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation.

Liu CT, Yang YJ, Yin F, Wang X, Yu XH, Wang QH, Wang XL, Xie M.

Cell Immunol. 2006 Nov;244(1):19-32. Epub 2007 Apr 19.

PMID:
17448455
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk